No Data
Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating
Akoya Biosciences (AKYA) has an average rating of outperform and price targets ranging from $6 to $11, according to analysts polled by Capital IQ. Price: 2.7926, Change: -0.11, Percent Change: -3.70
Express News | Akoya Biosciences Inc : Stephens Cuts Target Price to $6 From $7
Akoya Biosciences | 10-Q: Quarterly report
JAN, MTC and PROK Among Mid-day Movers
Akoya Biosciences Price Target Cut to $6.00/Share From $10.00 by Canaccord Genuity
Akoya Biosciences Price Target Cut to $6.00/Share From $10.00 by Canaccord Genuity
Akoya Biosciences Is Maintained at Buy by BTIG
Akoya Biosciences Is Maintained at Buy by BTIG